UK launches trial vaccine for brain cancer
The vaccine, called IMA950, has been designed to help the immune system to fight against glioblastoma, an aggressive and common form of brain cancer
Oct.
Publication Date:
20/10/2010
The vaccine, called IMA950, has been designed to help the immune system to fight against glioblastoma, an aggressive and common form of brain cancer
Oct.